Submitted:
18 April 2023
Posted:
19 April 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. COVID-19 vaccines. 2022 [cited 2022 December 7]; Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
- Randolph, H.E.; Barreiro, L.B. Herd Immunity: Understanding COVID-19. Immunity 2020, 52, 737–741. [Google Scholar] [CrossRef]
- Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
- Anderson, E.L. Recommended solutions to the barriers to immunization in children and adults. Mo Med. 2014, 111, 344–8. [Google Scholar] [PubMed]
- Team, T.B.I. , EAST:Four simple ways to apply behavioural insights. 2014.
- Bioethics, N.C.o. , Public health: ethical issues. 2007.
- Mertens, S.; Herberz, M.; Hahnel, U.J.J.; Brosch, T. The effectiveness of nudging: A meta-analysis of choice architecture interventions across behavioral domains. Proc. Natl. Acad. Sci. USA 2021, 119, e2107346118. [Google Scholar] [CrossRef] [PubMed]
- Thaler, R.H. and C.R. Sunstein, Nudge: Improving Decisions About Health, Wealth, and Happiness. 2009: Penguin Books.
- Smith, H.S.; Blumenthal-Barby, J.S.; Chatterjee, R.; Hindera, O.; Huang, A.; Kothari, R.; Vlaev, I. A Review of the MINDSPACE Framework for Nudging Health Promotion During Early Stages of the COVID-19 Pandemic. Popul. Heal. Manag. 2022, 25, 487–500. [Google Scholar] [CrossRef] [PubMed]
- Johnson, E.J. and D. Goldstein, Medicine. Do defaults save lives? Science, 2003, 302, 1338–9. [Google Scholar] [CrossRef] [PubMed]
- Chapman, G.B.; Li, M.; Colby, H.; Yoon, H. Opting In vs Opting Out of Influenza Vaccination. JAMA 2010, 304, 43–4. [Google Scholar] [CrossRef] [PubMed]
- Chapman, G. , et al., Default clinic appointments promote influenza vaccination uptake without a displacement effect. Behavioral Science & Policy, 2016.
- A Lehmann, B.; Chapman, G.B.; Franssen, F.M.; Kok, G.; Ruiter, R.A. Changing the default to promote influenza vaccination among health care workers. Vaccine 2016, 34, 1389–1392. [Google Scholar] [CrossRef] [PubMed]
- Cabinet Office, White Paper on Aging Society:2022 edition[in Japanese]. 2022.
- Cabinet Office. Aging of the population[in Japanese]. 2021 [cited 2022 December 7]; Available from: https://www8.cao.go.jp/kourei/whitepaper/w-2022/html/zenbun/s1_1_4.html.
- Ministry of Health, Labour and Welfare,, Summary of Life Tables by Prefecture, 2015[in Japanese]. 2015.
- Immunization Office, H.S.D. ,,Health Service Bureau,Ministry of Health, Labor and Welfare,, Allocation of Pfizer Vaccines after October 11[in Japanese]. 2021.
- Our World in Data. Coronavirus Pandemic (COVID-19). 2023 [cited 2023 January 25]; Available from: https://ourworldindata.org/coronavirus.
- Yoda, T.; Katsuyama, H. Willingness to Receive COVID-19 Vaccination in Japan. Vaccines 2021, 9, 48. [Google Scholar] [CrossRef] [PubMed]
- Dai, H.; Saccardo, S.; Han, M.A.; Roh, L.; Raja, N.; Vangala, S.; Modi, H.; Pandya, S.; Sloyan, M.; Croymans, D.M. Behavioural nudges increase COVID-19 vaccinations. Nature 2021, 597, 404–409. [Google Scholar] [CrossRef] [PubMed]
- Sunstein, C.R. and L.A. Reisch, Behavioral Economics in Data The "Truth about Nudges" Revealed in a Large-Scale Worldwide Survey [in Japanese]. 2020: Nikkei BP.
- Danziger, S., J. Levav, and L. Avnaim-Pesso, Extraneous factors in judicial decisions. Proc Natl Acad Sci U S A 2011, 108, 6889–92. [Google Scholar] [CrossRef] [PubMed]
| City | System | Dose | Total | 20-64 age | |||||
| 95% Confidence Interval | 95% Confidence Interval | ||||||||
| Minimum | Maximum | Minimum | Maximum | ||||||
| B | Opt-out | 1 | Nominated Population | 16,225 | 14,903 | ||||
| Vaccinated Population | 14,385 | 13,215 | |||||||
| Vaccination Coverage | 88.7% | 88.2% | 89.1% | 88.7% | 88.2% | 89.2% | |||
| 2 | Nominated Population | 16,225 | 14,903 | ||||||
| Vaccinated Population | 13,858 | 12,732 | |||||||
| Vaccination Coverage | 85.4% | 84.9% | 86.0% | 85.4% | 84.9% | 86.0% | |||
| C | Opt-in | 1 | Nominated Population | 255,534 | 137,471 | ||||
| Vaccinated Population | 214,584 | 110,670 | |||||||
| Vaccination Coverage | 84.0% | 83.8% | 84.1% | 80.5% | 80.3% | 80.7% | |||
| 2 | Nominated Population | 255,534 | 137,471 | ||||||
| Vaccinated Population | 190,501 | 93,857 | |||||||
| Vaccination Coverage | 74.6% | 74.4% | 74.7% | 68.3% | 68.0% | 68.5% | |||
| D | Opt-in | 1 | Nominated Population | 206,481 | 118,922 | ||||
| Vaccinated Population | 164,389 | 89,470 | |||||||
| Vaccination Coverage | 79.6% | 79.4% | 79.8% | 75.2% | 75.0% | 75.5% | |||
| 2 | Nominated Population | 206,481 | 118,922 | ||||||
| Vaccinated Population | 128,206 | 61,385 | |||||||
| Vaccination Coverage | 62.1% | 61.9% | 62.3% | 51.6% | 51.3% | 51.9% | |||
| E | Opt-in | 1 | Nominated Population | 153,075 | 87,354 | ||||
| Vaccinated Population | 119,929 | 63,791 | |||||||
| Vaccination Coverage | 78.3% | 78.1% | 78.6% | 73.0% | 72.7% | 73.3% | |||
| 2 | Nominated Population | 153,075 | 87,354 | ||||||
| Vaccinated Population | 99,856 | 48,219 | |||||||
| Vaccination Coverage | 65.2% | 65.0% | 65.5% | 55.2% | 54.9% | 55.5% | |||
| F | Opt-in | 1 | Nominated Population | 55,416 | 30,165 | ||||
| Vaccinated Population | 47,046 | 25,102 | |||||||
| Vaccination Coverage | 84.9% | 84.6% | 85.2% | 83.2% | 82.8% | 83.6% | |||
| 2 | Nominated Population | 55,416 | 30,165 | ||||||
| Vaccinated Population | 42,220 | 21,736 | |||||||
| Vaccination Coverage | 76.2% | 75.8% | 76.5% | 72.1% | 71.6% | 72.6% | |||
| G | Opt-in | 1 | Nominated Population | 48,811 | 26,743 | ||||
| Vaccinated Population | 40,390 | 20,623 | |||||||
| Vaccination Coverage | 82.7% | 82.4% | 83.1% | 77.1% | 76.6% | 77.6% | |||
| 2 | Nominated Population | 48,811 | 26,743 | ||||||
| Vaccinated Population | 34,713 | 15,751 | |||||||
| Vaccination Coverage | 71.1% | 70.7% | 71.5% | 58.9% | 58.3% | 59.5% | |||
| H | Opt-in | 1 | Nominated Population | 34,846 | 21,549 | ||||
| Vaccinated Population | 28,902 | 16,988 | |||||||
| Vaccination Coverage | 82.9% | 82.5% | 83.3% | 78.8% | 78.3% | 79.4% | |||
| 2 | Nominated Population | 34,846 | 21,549 | ||||||
| Vaccinated Population | 25,167 | 14,510 | |||||||
| Vaccination Coverage | 72.2% | 71.8% | 72.7% | 67.3% | 66.7% | 68.0% | |||
| I | Opt-in | 1 | Nominated Population | 28,800 | 14,582 | ||||
| Vaccinated Population | 23,319 | 11,111 | |||||||
| Vaccination Coverage | 81.0% | 80.5% | 81.4% | 76.2% | 75.5% | 76.9% | |||
| 2 | Nominated Population | 28,800 | 14,582 | ||||||
| Vaccinated Population | 19,968 | 8,463 | |||||||
| Vaccination Coverage | 69.3% | 68.8% | 69.9% | 58.0% | 57.2% | 58.8% | |||
| J | Opt-in | 1 | Nominated Population | 28,020 | 15,463 | ||||
| Vaccinated Population | 22,358 | 11,247 | |||||||
| Vaccination Coverage | 79.8% | 79.3% | 80.3% | 72.7% | 72.0% | 73.4% | |||
| 2 | Nominated Population | 26,790 | 15,463 | ||||||
| Vaccinated Population | 19,256 | 9,457 | |||||||
| Vaccination Coverage | 71.9% | 71.3% | 72.4% | 61.2% | 60.4% | 61.9% | |||
| Opt-in total | 1 | Nominated Population | 810,983 | 452,249 | |||||
| Vaccinated Population | 660,918 | 349,002 | |||||||
| Vaccination Coverage | 81.5% | 81.4% | 81.6% | 77.2% | 77.0% | 77.3% | |||
| 2 | Nominated Population | 809,753 | 452,249 | ||||||
| Vaccinated Population | 559,887 | 273,378 | |||||||
| Vaccination Coverage | 69.1% | 69.0% | 69.2% | 60.4% | 60.3% | 60.6% | |||
| TOTAL | 12-14 | 15-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-64 | 65-69 | 70-79 | 80-89 | 90-99 | 100 AND MORE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1ST OPT-IN | 9.7% | 14.6% | 19.1% | 18.8% | 12.3% | 10.3% | 7.9% | 6.7% | 7.6% | 7.2% | 8.8% | 11.3% | 10.0% |
| 1ST OPT-OUT | 11.3% | ー | 11.5% | 17.7% | 13.5% | 10.8% | 8.9% | 7.3% | ー | ー | ー | ー | ー |
| 2ND OPT-IN | 10.5% | 15.6% | 21.5% | 20.0% | 13.5% | 11.4% | 9.0% | 7.1% | 8.0% | 7.8% | 9.3% | 12.3% | 12.5% |
| 2ND OPT-OUT | 14.6% | ー | 14.8% | 22.6% | 17.1% | 14.0% | 11.6% | 9.4% | ー | ー | ー | ー | ー |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).